Odyssey Therapeutics, Inc. ODTX Q2 2026 earnings
Reported June 17, 2026 · Before market open
EPS estimate-$1.11
Next report
Sep 16, 2026 (in 3 months)EPS estimate-$0.89
Versus estimates
Diluted EPS
Q2 2026-$6.77Miss by $5.66
Ask the moment Odyssey Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Odyssey Therapeutics, Inc. report Q2 2026 earnings?
- Odyssey Therapeutics, Inc. (ODTX) reported Q2 2026 earnings on June 17, 2026 before market open.
- What were Odyssey Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- Odyssey Therapeutics, Inc. reported diluted EPS of $-6.77 for Q2 2026.
- Did Odyssey Therapeutics, Inc. beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-1.11 by $5.66.
- Where can I find Odyssey Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-274291) directly on SEC EDGAR. The filing index links above go to sec.gov.